Lipid Safety of Tenofovir Alafenamide During 96-Week Treatment in Treatment-Naive Chronic Hepatitis B Patients.

Wenjuan Zhao,Yi Liu, Mengdi Zhang,Zixin Cui, Zhan Qu,Yiyang Li,Meijuan Wan, Wen Wang,Yunru Chen,Lei Shi,Jianzhou Li,Feng Ye

Frontiers in medicine（2024）

引用 0|浏览8

暂无评分

关键词

tenofovir alafenamide,lipid safety,chronic hepatitis B,96-week,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要